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An emv-14-derived, replication-competent ecotropic murine leukemia virus [MuLV], designated AK7, was previously cloned
from the AKXL-5 recombinant inbred mouse strain and partially characterized. While genetically encoding for an envelopederived immunodominant CTL epitope [KSPWFTTL] located in the transmembrane region of p15TM, this virus, unlike the
emv-11-derived virus AKR623, fails to be efficiently recognized by AKR/Gross MuLV-specific cytotoxic T lymphocytes [CTL].
AK7 thus provides the opportunity to study the role of retroviral sequence variations that are located outside of the
immunodominant epitope as a mechanism of escape from CTL-mediated immune survellience. In an attempt to identify
which region[s] of the AK7 genome could account for its ability to evade efficient recognition by AKR/Gross MuLV-specific
CTL, we have constructed recombinant murine retroviruses. The direct influence of a sequence variation twelve amino
acids N-terminal to KSPWFTTL was explored with the use of chimeric viruses and determined not to significantly impair
the presentation of KSPWFTTL to AKR/Gross MuLV-specific CTL. The long terminal repeat [LTR] derived from the AK7
virus, which possesses only one copy of the 99-base pair transcriptional enhancer in the U3 region, in contrast to AKR623
that possesses two copies of the tandem direct repeat enhancers, was also analyzed for its influence on the presentation
of KSPWFTTL. Interestingly, our data indicate that the enhancer region derived from AK7 negatively influences the presentation of KSPWFTTL in the context of a recombinant AKR623 virus. q 1997 Academic Press

INTRODUCTION

brane region [TM] of the envelope protein in almost all
emv studied [Coppola et al., 1995] and many MCF MuLV
[Sijts et al., 1994; Coppola and Green, 1994].
Three highly related endogenous emv proviruses
found in AKR mice, emv-11, emv-13, and emv-14, were
previously studied. AKXL recombinant inbred mice, generated from the AKR and C57L progenitor strains, allowed
for the independent segregation of these endogenous
emv [Steffen et al., 1982]. Interestingly, splenocytes from
emv-14 positive AKXL-5 mice failed to stimulate an AKR/
Gross MuLV-specific CTL response in responder C57BL/
6 mice while splenocytes from emv-11-positive AKXL
mice successfully stimulated the response [Green and
Graziano, 1986]. When AKXL mice were used as the responders to generate an AKR/Gross MuLV-specific CTL
response, a clear pattern emerged where emv-14 negative AKXL-29 mice could mount a full AKR/Gross MuLVspecific CTL response, while emv-14-positive AKXL-5
mice were only partially responsive [Green and Rich,
1988]. Furthermore, AKR/Gross MuLV-specific CTL-recognized SC.Kb cells infected with virus isolated from emv11-positive AKXL-21 mice very efficiently. In contrast,
SC.Kb cells infected from virus derived from emv-14-positive AKXL-5 mice were poorly recognized [White et al.,
1990]. Subsequent molecular cloning of the ecotropic
AK7 MuLV, derived from emv-14-positive AKXL-5 mice,
led to the observation that AK7-infected cells were inefficiently recognized by AKR/Gross MuLV-specific CTL, in
contrast to cells infected by the emv-11-derived molecu-

k

AKR [H-2 ] mice have a high incidence of spontaneously occuring leukemias believed to be proximally induced by thymotropic mink cell focus-inducing [MCF]
retroviruses of the AKR/Gross type. MCF retroviruses are
dualtropic, capable of infecting both murine as well as
xenogeneic cells, and are formed from the recombination
of expressed endogenous ecotropic murine leukemia viruses [emv] with other endogenous xenotropic and polytropic murine leukemia viral sequences [Hartley et al.,
1977; Stoye et al., 1991; Elder et al., 1977; Chattopadhyay
et al., 1981; Cloyd et al., 1985; Khan, 1984]. The generation of these leukemogenic MCF retroviruses is thus dependent upon the expression of ecotropic MuLV. C57BL/
6 [H-2b] mice have a much lower incidence of spontaneously occuring thymic leukemias and have been shown
to generate vigorous H-2Kb-restricted CTL responses
against tumors induced by the AKR/Gross MuLV [Green
et al., 1979, 1980]. In contrast, AKR mice were unable to
mount H-2k restricted anti-AKR/Gross MuLV CTL responses [Green, 1984]. The C57BL/6-derived T lymphocytes, designated as AKR/Gross MuLV-specific CTL, are
directed specifically against an immunodominant T cell
epitope [KSPWFTTL] [White et al., 1994a; Sijts et al., 1994;
Green and Smith, 1996] located in the p15 transmem1
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lar clone AKR623 which were very efficiently recognized
[White et al., 1993]. These findings were curious since
both AK7 and AKR623 genetically encoded for the immunodominant KSPWFTTL epitope at TM134–141. Recognition of AK7 MuLV infected cells by AKR/Gross MuLVspecific CTL was dramatically improved, however, when
AK7-infected cells were exogenously pulsed with the
synthetic peptide KSPWFTTL, suggesting that there was
a defect in the presentation of KSPWFTTL that should
be endogenously produced from this virus [White et al.,
1994b]. Partial sequencing [H. D. White; unpublished observations] of the AK7 retrovirus has elucidated two significant differences, when compared to the efficiently recognized AKR623 virus, that could potentially account for
a negative influence on KSPWFTTL presentation. In this
report, we investigated the possibility that either a flanking sequence variation located twleve amino acids Nterminal to KSPWFTTL and/or a distal variation located
in the U3 region of the long terminal repeat [LTR] encoded by the AK7 MuLV is responsible for the failure of
AK7 virally infected cells to be efficiently recognized by
AKR/Gross MuLV-specific CTL.
MATERIALS AND METHODS
Cell lines
The SC-1 cell line is a continuous fibroblast line from a
feral mouse embryo and is cultured in Dulbecco modified
Eagle medium supplemented with 5% fetal bovine serum,
2 mM L-glutamine, 33 mg gentamycin per milliliter, 30 mg
of penicillin per milliliter, and 20 mg of streptomycin per
milliliter. The MHC class I H-2Kb gene was introduced
into SC-1 giving rise to SC.Kb as previously described
[White et al., 1990]. B.GV and E?G2 are H-2b Gross virus
cell surface antigen [GCSA]-positive tumor cell lines derived from a BALB.B congenic and a C57BL/6 mouse,
respectively, both induced with the Gross virus passage
A MuLV. AKR.H-2b SL1 is a GCSA-positive tumor cell line
derived from a spontaneous leukemia from an AKR.H-2b
congenic mouse. YAC-1 [YAC] is an H-2a tumor cell line
that is used here as a highly natural killer [NK]-sensitive
target cell. The B.GV, E?G2, YAC, and AKR.H-2b SL1
tumor cell lines were grown in RPMI supplemented with
5% fetal bovine serum, 2 mM L-glutamate, 33 mg gentamycin per milliliter, 50 mM 2-mercaptoethanol, 30 mg of
penicillin per milliliter, and 20 mg of streptomycin per
milliliter. EL4[S] is a C57BL/6-derived T cell lymphoma,
and EG7 is a clone of EL4 that has been transfected with
an ovalbumin [OVA] cDNA [Moore et al., 1988]. RF33.70 is
a C57BL/6-derived anti-OVA-specific T-T cell hybridoma
[Rock et al., 1990]. The EG7 and RF33.70 cell lines were
grown in either DMEM or RPMI, respectively, both supplemented with 10% fetal bovine serum, 33 mg gentamycin per milliliter, 30 mg of penicillin per milliliter, and
20 mg of streptomycin per milliliter. All cell lines were
maintained at 377 in a 5% CO2 atmosphere.
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Viruses
The BM5 ecotropic TM 122E/134K and BM5 ecotropic
TM 122K/134K retroviral recombinants were constructed
by excising the 846-bp BssHII/XbaI fragment from the
parental plasmid pBM5 eco and inserting it into the
BssHII/XbaI site in the polylinker region of the plasmid
pNEB193 [New England Biolabs] resulting in the plasmid
designated as pNEB-RS1. The 3537-bp XbaI/BstXI fragment from pNEB-RS1 was then ligated to the 260-bp
XbaI/BstXI fragment derived from either the pAKR623 or
pAK7 plasmids resulting in the plasmids pNEB-RS1 [623]
or pNEB-RS1 [7], respectively. The 846-bp BssHII/XbaI
fragment from either pNEB-RS1 [623] or pNEB-RS1 [7]
was then inserted into the 12-kb BssHII/XbaI fragment
from pBM5 eco resulting in the plasmids pBM5 eco TM
122E/134K and pBM5 eco TM 122K/134K. The resulting
pBM5 eco TM 122E/134K and pBM5 eco TM 122K/134K
constructs were then introduced into SC-1 cells by calcium-phosphate-mediated transfection.
The AKR623/7 LTR viral chimera was constructed by
excising the 388-bp BssHII fragment from pAK7, which
contains only a single copy enhancer, and ligating it to
the pAKR623-derived 10540-bp BssHII fragment, from
which the tandem direct repeat sequences were already
removed. The resulting pAKR623/7 LTR construct was
then introduced into SC-1 cells by calcium-phosphatemediated cotransfection with the plasmid pSV2His. Supernatants from SC-1 cells transfected with pBM5eco
TM 122E/134K, pBM5 eco TM 122K/134K, or AKR 623/7
LTR were then collected, briefly spun down, and filtered
before using to infect SC.Kb cells that had been cultured
in the presence of polybrene for at least 12 hr. Infected
SC.Kb cells were then subjected to FACS analysis using
the antiviral-specific monoclonal antibodies 24-8, a murine IgG2a mAb specific for emv gp70, and 548 which is
a murine IgG2b mAb specific for the p12 [gag] antigen.
Recombinant vaccinia virus encoding for H-2Kb [vaccinia Kb] was kindly provided by Dr. Jack Bennink [NIAID/
NIH] and was used to infect SC-1, SC-1 BM5 ecotropic
TM 122E/134K, and SC-1 BM5 ecotropic TM 122K/134K
cells at a multiplicity of infection [m.o.i.] of 10:1 for 1
hr in BSS/BSA. Vaccinia virus-infected cells were then
incubated in DMEM media containing 5% fetal bovine
serum for 4 hr before conducting the CTL assay.
RT-PCR and DNA sequencing
The pBM5 eco TM 122E/134K, pBM5 eco TM 122K/134K,
and pAKR623/7 LTR generated plasmid constructs were
sequenced by thermal cycle dideoxy DNA sequencing
[New England Biolabs] using the M13/pUC [040] oligonucleotide 5*-GTTTTCCCAGTCACGAC-3* and the M13/pUC
[048] oligonucleotide 5*-AGCGGATAACAATTTCACACAGGA-3* to confirm TM122E-TM134K, TM122K-TM134K, and
the enhancer region of the LTR, respectively. The SC.Kb
BM5 eco TM 122E/134K- and SC.Kb BM5 eco TM 122K/
134K-infected cell lines were confirmed for the TM122E-
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TM134K and TM122K-TM134K regions, respectively, by RTPCR sequencing using Taq polymerase [Perkin–Elmer].
PCR was conducted on extracted RNA [Sigma] reverse
transcribed into cDNA [Boehringer-Mannheim] with PCR
conditions set at 957 1 min, 557 1 min, 727 2 min for 25
cycles, and directly sequencing the 222-bp PCR product
using the oligonucleotides 623/7499 5*-GTACGGGATAGCATGGCCAAACTTAGAGAA-3* and 623/7694 5*-CTACCGAAATCCTGTCTTTGATAAACTG-3*. The SC.Kb 623/7 LTR
cell line was confirmed for the AK7-derived enhancer region
by RT-PCR and direct sequencing using the oligonucleotides LTR[/] 5*-GCAAGGCATGGGAAAATACCAGAGCTGATG-3* and LTR[0] 5*-TCCCCGGTCATCTGGGGAACCTTGAGACAG-3*. The oligonucleotides 623/7499, 623/7694,
LTR[/], and LTR[0] were synthesized at the Dartmouth
College Molecular Biology Core Facility.
Assay for cell-mediated cytotoxicitiy
AKR/Gross MuLV-specific CTL were generated by immunizing C57BL/6 male mice with 2 1 106 B.GV cells
i.p. Approximately 10 days later, the spleen cells were
harvested and cultured with irradiated [8000 rads] E?G2
or AKR.H-2b SL1 stimulator cells at a responder to stimulator ratio of 40:1 or with stimulating KSPWFTTL peptide
at 10 mg/ml at 377 in a 5% CO2 atmosphere. AntiH-2b
allogeneic CTL were generated by culturing BALB/c
splenocytes with irradiated [2000 rads] C57BL/6 splenocytes at a responder to stimulator ratio of 2:1. After 6
days in culture, effector cells were harvested and incubated with 51Cr- labeled target cells at various effectorto-target [E:T] ratios at 377 in a 5% CO2 atmosphere for
6 hr in the case for fibroblast targets or 4 hr for tumor
targets. NK-sensitive YAC target cells were included in
all CTL assays and always observed to lyse at values
less than 2%. Percentage of specific lysis was calculated
according to the following formula: {[A 0 B] 4 C} 1 100
where A Å 51Cr released from target cells incubated with
CTL, B Å 51Cr released by target cells incubated alone,
and C Å total freeze–thaw releasable 51Cr [approximately 80%]. Lytic unit values were defined as the number of effectors required for 30% lysis and were determined by plotting percentage of lysis values versus the
log of the effector cell number and expressed as the
number of lytic units per 106 effector cells.
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a murine IgM antibody [Ozato et al., 1981], and HB158
[Pharmingen], an affinity purified mouse IgG2a mAb were
also used.
Flow cytometric analysis
Cell surface antigen expression was measured by indirect immunofluorescence. Then 1 1 106 cells washed
with staining medium consisting of RPMI 1640 containing
0.2 % [wt/vol] bovine serum albumin [Sigma Chemical]
were incubated with the appropriately diluted mAb for 1
hr at 47. The samples were washed twice in staining
medium and then treated with the appropriately diluted
FITC-conjugated secondary antibody [goat anti-mouse or
goat anti-rat immunoglobulin]. Cells were incubated at
47 for 1 hr with the secondary antibody and then washed
once with staining medium before fixing the cells in 1%
parafomaldehyde. Background fluorescence values were
determined with the following irrelevant monoclonal antibodies used as isotype controls: OKT8 [CRL 8014, murine
IgG2a] for 24-8, 9E8 and HB158; OKM1 [CRL 8026, murine
IgG2b] for 19VIII-E8; 35-12 [murine IgM] for HB41; and
purified rat IgG2a for 35/299. Flow cytometry analysis
was performed on a FACScan [Becton–Dickinson immunocytometry systems] set on a linear amplifier.
IL-2 biosassy
The IL-2 content in stimulated T cell hybridoma culture
supernatants was measured in a quantitative bioassay
with CTLL-2 indicator cells [Gillis et al., 1978]. Hybridoma
cultures were prepared with 105 RF33.70 cells in the
presence or absence of various antigen presenting cells
[APC] in 200 ml media in flat bottom microtiter wells in
duplicate. After a 20-hr incubation at 377, serial dilutions
of the stimulated versus control hybridoma supernatants
were tested for their ability to support the proliferation
of the highly IL-2-sensitive CTLL-2 cell line.
RESULTS
TM122K does not appear to negatively influence the
presentation of the TM134-141 CTL epitope
[KSPWFTTL] in SC.Kb cells

Two monoclonal antibodies [mAb] specific for gp70
were used: 35/299, a rat IgG2a mAb specific for ecotropic
gp70 [Pinter et al, 1982]; and 24-8, a murine IgG2a mAb
with a broad specificity for the gp70-p15E-associated
complex [Portis et al., 1982]. Two mAbs specific for
p15TM were also used: 9E8, an ascites-derived murine
IgG2a mAb specific for the p15Ea determinant [Lostrom
et al., 1979]; and 19VIII-E8, an ascites-derived murine
IgG2b mAb specific for the p15Eb determinant [Lostrom
et al., 1979]. The H-2Kb-specific mAb HB41 [28-13-3s],

To identify which region[s] of the AK7 MuLV genome
could account for its ability to evade efficient recognition
by AKR/Gross MuLV-specific CTL, known sequences of
the AK7 MuLV were compared to the very efficiently recognized AKR623 MuLV since these are two very similar
viruses, having originated from a common primordial emv
[Steffen et al., 1982]. Sequencing in the vicinity of KSPWFTTL in the p15TM region of the envelope gene revealed that AK7 encodes for a predicted lysine at position
TM122 instead of the glutamic acid residue found in the
AKR623, SL3-3, and MCF247 viruses that are representative of viruses efficiently recognized by AKR/Gross MuLVspecific CTL [Coppola and Green, 1994; White et al.,
1993] [Fig. 1A].
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FIG. 1. Comparative sequences of the AKR623 [Herr, 1984], SL3-3 [Lenz], MCF247 [Kelly et al., 1983], and AK7 [this study] retroviruses. A represents
amino acid sequences corresponding to TM117–149 found within the p15TM region of the envelope gene. The immunodominant KSPWFTTL peptide
is underlined. The nucleotides GAA found in AKR623, SL3-3, and MCF247 encode for the negatively charged glutamate while the AK7-derived AAA
sequence encode for a positively charged lysine residue at amino acid position 122. The data documenting the relative susceptibilities of cells
infected by these retroviruses to AKR/Gross MuLV-specific CTL was derived from published studies [Coppola and Green, 1994; White et al., 1993].
The determination for SL3-3 was done with NB-tropic SL3-3 [Coppola et al., 1996; Thomas et al., 1993]. B illustrates the nucleotide sequence of a
single copy of the transcriptional enhancer found in the U3 region of the LTR. The single copy of the AK7 transcriptional enhancer is identical to
either of the two AKR623 tandem direct repeats with the exception of a T insertion followed immediately by a G r A substituion. (GenBank Accession
No. AF019257).

To explore the possibility that CTL epitope processing
and/or presentation might be affected by this nonconservative change, we examined this sequence variation for its
specific influence on the presentation of KSPWFTTL. Two
viral chimeras were constructed utilizing the BM5 ecotropic
virus as the viral backbone [Fig. 2]. The highly infectious
BM5 ecotropic virus is normally not recognized by H-2Kbrestricted AKR/Gross MuLV-specific CTL since it encodes
for RSPWFTTL instead of KSPWFTTL at TM134-141 [Coppola
et al., 1995]. Two recombinant retroviruses, BM5 ecotropic
TM 122E/134K and BM5 ecotropic TM 122K/134K, were generated so that they both encoded for the KSPWFTTL epitope,

but with either a glutamate or a lysine, respectively, at position TM122. Positioning the KSPWFTTL epitope along with
the corresponding TM122-encoded amino acid in a common
viral backbone in this fashion thus allowed us to directly
study the influence of this flanking sequence variation on the
presentation of KSPWFTTL. SC-1 fibroblast cells expressing
either of the two chimeric retroviruses were then assayed
at the target level against H-2Kb-restricted AKR/Gross MuLVspecific CTL, derived from C57BL/6 mice by in vivo priming
and secondary in vitro stimulation with MHC compatible
AKR/Gross MuLV-induced tumor cells, as demonstrated previously in our lab [Green, 1982]. To introduce the MHC re-
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FIG. 2. Construction strategy of the BM5 ecotropic TM 122E/134K and BM5 ecotropic TM 122K/134K viral chimeras used in this study as detailed
under Materials and Methods. The steps leading to the formation of pNEB-RS1 have not been depicted for clarity.

striction element into these cells, recombinant vaccinia virus
encoding for H-2Kb was used to infect the SC-1 cells containing either chimeric retrovirus.
Figure 3 shows that vaccinia virus Kb-infected target
cells containing the BM5 ecotropic TM 122K/134K viral
chimera, which harbors the TM122K variation derived from
the AK7 MuLV, were recognized with a similar degree of
efficiency as the BM5 ecotropic TM 122E/134K viral chimera which contains the normal glutamate at TM122 derived from the AKR623 virus. This experiment was performed three times with similar results. To further validate
this finding and demonstrate that these results were not
due to an artifact, such as a crossreactive epitope introduced by the vaccinia virus infection, or were influenced
by a limitation in the Kb expression levels that could be
achieved by the recombinant vaccinia virus infection, the
previously characterized SC.Kb cell line was alternatively
used at the target level since it endogenously produces
the appropriate restriction element. As Fig. 4 demonstrates, SC.Kb target cells, whether infected by the BM5
ecotropic TM 122K/134K or the BM5 ecotropic TM 122E/
134K viral chimera, were also recognized with similar efficiencies by the AKR/Gross MuLV-specific CTL. This exper-

iment was performed three times with similar results. Although the data displayed in Figs. 3 and 4 suggest that
the BM5 ecotropic TM 122K/134K viral chimera may be
slightly more efficiently recognized than the BM5 ecotropic
TM 122E/134K viral chimera, repeated experiments have
indicated that this small difference was not a consistent
and significant result. RT-PCR was performed from the
RNA extracted from these two infected SC.Kb cell lines,
and direct sequencing of the PCR products confirmed
the identity of both chimeric retroviruses. These results
collectively suggested that the flanking amino acid sequence variation from glutamate to lysine found at position
TM122 in the AK7 MuLV does not negatively impact the
final presentation of the immunodominant KSPWFTTL epitope to H-2Kb-restricted antiviral CTL.
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The AK7-derived transcriptional enhancer partially
influences the ability of AKR623/7 LTR-infected cells
to be recognized
Another region of the AK7 MuLV genome that could
have potentially accounted for the inefficient recognition
of AK7 MuLV-infected cells by AKR/Gross MuLV-specific
CTL was its long terminal repeat [LTR]. It was previously
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FIG. 3. TM122K does not negatively influence TM134–141 processing and presentation in vaccinia Kb infected SC-1 cells. SC-1 cells harboring either
the BM5 eco TM 122E/134K or the BM5 eco TM 122K/134K chimeric virus were infected with the recombinant vaccinia Kb virus at a multiplicity of
infection of 10:1 5 hr before the B.GV-primed and E?G2 tumor-stimulated AKR/Gross MuLV-specific CTL were added at an effector to target ratio of
100:1 in a standard chromium release assay as described under Materials and Methods. Target cell spontaneous release values ranged from 6 to 9%.

demonstrated by RFLP analysis that the AK7 retrovirus
contains only a single copy of the 99-bp transcriptional
enhancer found in the U3 region of its LTR [White et al.,
1993], while in contrast, the AKR623 retrovirus contains
two copies of the enhancer, otherwise known as the tandem direct repeat sequences. Other than this difference,
sequencing of this region has revealed that AK7 has a
highly homologous enhancer sequence when compared
to AKR623 [this study]. In fact, the AK7 enhancer sequence
only differs from the AKR623 sequence by two nucleotides
as depicted in Fig. 1B. This difference in sequence allowed for the easy and definitive identification of the two
different LTRs even if a spontaneous tandem duplication
of the AK7 LTR direct repeat had occured.
In order to explore what influence the AK7 retroviral
LTR had on the presentation of KSPWFTTL, a viral chimera was constructed in the context of the AKR623 retrovirus. The AKR623/7 LTR recombinant retrovirus has its
LTR derived from AKR623, with the exception that the
tandem direct repeat sequences were excised and replaced with the single copy enhancer sequence derived
from the AK7 viral LTR. As demonstrated in Figs. 5A and
5B, SC.Kb cells infected with the AKR623/7 LTR retroviral
chimera were recognized at levels intermediate to that

of AKR623 or AK7 infected cells, based either on examination of specific lysis values or on lytic unit calculations
[legend to Fig. 5]. This experiment was conducted a total
of four times with Fig. 5A representing one such experiment and Fig. 5B depicting the average of the three other
experiments. Although there was some variation in the
degree of recognition by antiviral CTL of cells infected
by the AKR623/7 LTR chimeric virus, relative to AKR623or AK7-infected SC.Kb cells, SC.Kb cells infected by the
AKR623/7 LTR chimera were never as poorly recognized
as AK7-infected cells, indicating the existence of other
AK7 sequences that interfered with the functional presentation of peptide 12. RT-PCR was performed from the
RNA extracted from the AKR623/7 LTR-infected SC.Kb cell
line and direct sequencing of the PCR product verified
the presence of only the AK7-derived enhancer. These
data thus collectively suggest that the transcriptional enhancer derived from AK7 played an important, but not
the only, negative role in the presentation of KSPWFTTL.
Retroviral LTR enhancer regions are generally considered to function as a positive regulator of viral transcription. As Fig. 1B depicts, the AK7 retrovirus contains only
a single copy of the 99-bp transcriptional enhancer found
in the U3 region of its LTR while the AKR623 virus pos-
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FIG. 4. TM122K does not negatively influence TM134–141 CTL epitope processing and presentation in SC.Kb cells. SC.Kb cells infected with either
the BM5 Eco TM 122E/134K or the BM5 Eco TM 122K/134K chimeric retrovirus were used as target cells in a standard chromium release assay with
B.GV-primed and AKR.H-2b.SL1 tumor-stimulated AKR/Gross MuLV-specific CTL. Target cell spontaneous release values ranged from 15 to 23%.

sesses two copies of the enhancer. To address whether
viral env gene expression was equivalent at the protein
level for AKR623 versus AK7-infected SC.Kb cells, flow
cytometry was utilized to quantitate gp70 and p15TM. As
demonstrated in Fig. 6, the data for mAb 35/299, which
detects gp70; as well as for 9E8, which is specific for
p15TM; show that both gp70 and p15TM are expressed
at either roughly equivalent or greater levels in AK7-infected SC.Kb cells in comparison to AKR623-infected
SC.Kb cells. The mAb 24-8, which recognizes the viral
gp70-p15E-associated complex, and the mAb 19VIII-E8,
specific for p15TM, were also used to confirm that SC.Kb
cells infected with AK7 expressed at least as much cell
surface gp70 and p15TM as AKR623 infected SC.Kb cells
[data not shown]. Thus, the inefficient recognition of AK7infected SC.Kb cells by AKR/Gross MuLV-specific CTL
that was consistently observed previously [White et al.,
1993 and 1994b] and here in Figs. 5A and 5B was not
due to lower levels of expression of either the envelope
protein or more specifically, p15TM, within which peptide
12 is located. Figure 6 also demonstrates that the cell
surface expression levels for H-2Kb, the restriction element for peptide 12 presentation, were essentially the
same in either AKR623 or AK7 infected SC.Kb cells. Similar results were also obtained with a second H-2Kb specific mAb [HB158, data not shown].
DISCUSSION
In summary, previous experiments have demonstrated
that when SC.Kb fibroblast target cells, infected with ei-

ther AKR623 [emv-11 derived] or AK7 [emv-14 derived]
and expressing similar steady state levels of retroviral
antigens were compared, AKR/Gross MuLV-specific CTL
recognized AKR623-infected cells much more efficiently
than AK7-infected cells [White et al., 1993]. Recognition
of AK7 virally infected SC.Kb cells by AKR/Gross MuLVspecific CTL was dramatically improved when these cells
were exogenously pulsed with the synthetic KSPWFTTL
peptide representing the immunodominant CTL epitope
[White et al., 1994b]. These findings were intriguing since
AK7 genetically encoded for KSPWFTTL [Fig. 1], suggesting that a defect in KSPWFTTL processing and presentation was occuring. Allogeneic CTL directed against
H-2b had also been used to demonstrate that the failure
of emv-14-infected SC.Kb cells to be efficiently recognized
by AKR/Gross MuLV-specific CTL was not due to the
downregulation of MHC class I [White et al., 1990].
One alternative mechanism that we address in the
present study is the influence of sequence variations
encoded by AK7 that may affect KSPWFTTL processing
and/or presentation. CTL recognize antigens as short
peptides bound to the MHC class I molecule, thus imposing the requirement that viral proteins be proteolytically
processed before they can be presented to T cells. As
a result, not only are the recently defined MHC class I
allele-specific motifs important [Rammensee et al., 1993
and 1995], but the cleavage preferences of the proteasomal complex could potentially affect the availability of
peptides either quantitatively and/or qualitatively [Eggers
et al., 1995; Niedermann et al., 1995]. The specific mecha-
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nism of the proteolytic machinery that cleaves endogenously synthesized viral proteins into smaller peptides
is incompletely understood, and flanking sequences may
hinder the creation of immunogenic peptides, such as
by making the epitopes more sensitive to proteolysis,
resulting in smaller nonantigenic peptides [Niedermann
et al., 1995; Ossendorp et al., 1996]. In addition to the
possibility of affecting proteolysis of the viral proteins,
flanking sequence variations with respect to the immunodominant KSPWFTTL could also influence the effectiveness of KSPWFTTL containing peptides to be translocated, via the TAP transporters, into the lumen of the ER
for the subsequent binding to class I [Neisig et al., 1995].
Moreover, when KSPWFTTL containing peptides are
translocated into the ER, the possibility exists that flanking sequences may affect the ability to trim the peptides
to the appropriate size for MHC class I binding. The
precise role of flanking sequences in MHC class I antigen presentation, however, is not fully understood and
remains controversial. While evidence has been reported
demonstrating that flanking sequences can influence the
presentation of MHC class I-restricted peptides, other
cases exist where no influence is observed as well [Egger et al., 1995; Niedermann et al., 1995; Ossendorp et
al., 1996; Neisig et al., 1995; Eisenlohr et al., 1992; Koup,
1994; Del Val et al., 1991; Hahn et al., 1991 and 1992; Fu
et al., 1993; Mylin et al., 1995; Bergmann et al., 1994 and
1996; Shastri et al., 1995; Couillin et al., 1994; Chimini et
al., 1989; Yellen-Shaw et al., 1997a and 1997b].
We approached these possibilities by constructing retroviral chimeras. To directly assess the influence of the
only proximally located flanking sequence variation encoded by AK7, we positioned a small region containing
the KSPWFTTL epitope along with the corresponding lysine or glutamate flanking sequence variation [Fig. 1],
into a common viral backbone [BM5 ecotropic]. In the
data presented in this report, we find that the existence
of a positively charged lysine at position TM122, as opposed to a negatively charged glutamate, 12 amino acids
N-terminal to KSPWFTTL in AK7 does not negatively impact the presentation of the immunodominat KSPWFTTL.
This direct comparison was performed both in vaccinia
Kb-infected SC-1 cells and in SC.Kb cells, the latter in
which there should have been no limitation of expression
of the Kb restricting element or complicating factors due
to vaccinia virus infection. Our findings thus suggest that
the processing and presentation machinery involved in
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the display of KSPWFTTL to H-2Kb-restricted CTL is not
influenced by the specific TM122K variation.
The other prominent disparity between the AK7 and
AKR623 viruses resides within the U3 region of the LTR.
The U3 region of the retroviral LTR contains the transcriptional promoter and enhancer elements that are required
for viral gene expression. The transcriptional enhancer region found in the murine retroviral LTR is usually observed
as a direct repeat of 50 to 100 nucleotides and contains
binding sites for various cellular transcription factors
[Speck and Baltimore, 1987]. Studies on the pathogenesis
of murine retroviruses have demonstrated that a crucial
determinant of viral leukemogenicity is the transcriptional
enhancer found within the U3 region of the LTR [Speck et
al., 1990; DesGroseillers and Jolicoeur, 1984; Morrison et
al., 1995]. Our lab has previously characterized the AK7
MuLV as having only one copy of the transciptional enhancer found in the U3 region as depicted in Fig. 1B [White
et al., 1993]. Interestingly, the AK7 virus differs in its single
enhancer copy from AKR623 by two nucleotides [Fig. 1B]
within the binding site for the transcription factor TEF-I
[Lovmand et al., 1990; Davidson et al., 1988]. In this study,
we have constructed a chimeric AKR623 retrovirus where
we replaced its normal tandem direct repeat sequences
with the single enhancer copy derived from the AK7 MuLV.
If AK7-infected cells are inefficiently recognized by AKR/
Gross MuLV-specific CTL solely due to the single copy of
the transcriptional enhancer, then it would be predicted
that the AKR623/7 LTR chimeric virus would similarly be
inefficiently recognzied. Testing SC.Kb cells infected with
this chimeric retrovirus against AKR/Gross MuLV-specific
CTL has demonstrated that recognition by AKR/Gross
MuLV-specific CTL occurs at levels intermediate to that of
AKR623 and AK7-infected SC.Kb cells [Figs. 5A and 5B].
This experiment was performed four times and included
the use of allogeneic CTL directed against H-2b as an
internal control for Kb expression levels [data not shown].
While variable susceptibilities to anti-H-2b allogeneic CTL
were sometimes observed, even when normalizing for the
differential levels of allogeneic CTL susceptibilites, the
overall interpretation that AKR623/7 LTR-infected SC.Kb
cells are at lysis levels intermediate to that of AKR623and AK7-infected cells by AKR/Gross MuLV-specific CTL
remains consistent. When H-2Kb expression levels were
monitored by flow cytometry, it was found that both
AKR623- and AK7-infected SC.Kb cells expressed H-2Kb at
essentially equivalent levels [Fig. 6].

FIG. 5. The AKR623/7 LTR chimeric virus is recognized by anti-AKR/Gross MuLV-specific CTL at a level intermediate to that of SC.Kb cells infected
by AKR623 or AK7 MuLV. The AKR623/7 LTR viral chimera was used here to study the role of the AK7-derived enhancer on KSPWFTTL presentation.
The AKR623/7 LTR viral chimera is essentially the AKR623 virus with its enhancer regions replaced with the single enhancer region derived from
the AK7 LTR as detailed under Materials and Methods. SC.Kb cells infected with the AKR623/7 LTR chimeric retrovirus were used in a standard
chromium release assay with AKR/Gross MuLV-specific CTL raised by B.GV tumor priming and either AKR.H-2b.SL1 [A] or E?G2 [B] tumor
restimulation. A is a representative experiment while B depicts the averaged data of three other independent experiments. Target cell spontaneous
release values ranged from 16 to 38%. These data were also analyzed for lytic units [LU]. The lysis curves corresponded to the following: (A) SC.Kb
cells infected with AKR623, 57 LU/106 cells; SC.Kb cells infected with AKR623/7 LTR, 41 LU/106 cells; (B) SC.Kb cells infected with AKR623, 22 LU/
106 cells; SC.Kb cells infected with AKR623/7 LTR, 4 LU/106 cells. In both A and B, the lysis of SC.Kb and SC.Kb cells infected with AK7 corresponds
to less than 1 LU/106 cells.
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FIG. 6. The CTL restriction element, H-2Kb, and the viral envelope proteins gp70 and p15TM are expressed either equivalently or at somewhat
greater levels in SC.Kb cells infected with the AK7 virus in comparison to cells infected by the AKR623 virus. Cell surface antigen expression was
analyzed by indirect immunofluoresence as described under Materials and Methods. The results are displayed as the difference of the total mean
fluoresence intensity [TMFI] values of the indicated experimental mAbs from which the background fluoresence TMFI of the matched isotype control
was subtracted.

Collectively, these experiments suggest that because
the AK7-derived transcriptional enhancer does not fully
abrogate the ability of AKR623/7 LTR-infected cells to be
recognized by AKR/Gross MuLV-specific CTL, the presence of only one copy of the transcriptional enhancer
was sufficient for the processing and presentation of
at least some of the KSPWFTTL CTL determinant. The
observation that the AKR623/7 LTR chimeric was generally not as efficiently recognized as AKR623-infected
cells, however, indicates that the introduction of the AK7derived enhancer had a negative impact upon the ability
to be recognized by AKR/Gross MuLV-specific CTL. Consequently, these data support the hypothesis that the
deficiency of one copy of the AK7-derived transcriptional
enhancer is an important, albeit incomplete, explanation
for the inefficient levels of recognition of AK7-infected
cells by AKR/Gross MuLV-specific CTL.
Consistent with the idea that multiple enhancers may
be more effective at increasing transcription rates than
a single enhancer copy [Lovmand et al., 1990; Graves et
al., 1985; Boral et al., 1989; Hallberg and Grundstrom,
1988; Losardo et al., 1989; Etzerodt et al., 1990], it was
also observed that infection by AK7 spreads more slowly
than AKR623 [White et al., 1993]. Previous studies, how-

ever, examining the relative antiviral CTL susceptibilities
of AKR623 versus AK7-infected SC.Kb cells have demonstrated that when the infection by AK7 was allowed to
proceed until the cell surface viral antigen display
reached steady-state and equivalent levels as AKR623infected SC.Kb cells, that AK7 was still inefficiently recognized by AKR/Gross MuLV-specific CTL [White et al.,
1993]. Indeed, relative to the present studies, Fig. 6
clearly demonstrates that by flow cytometric analysis,
AK7 causes the accumulation of at least as much of the
viral proteins env, gp70, and p15TM when compared to
AKR623. Rather than quantitatively lower overall levels
of expression of either the env or p15TM proteins as the
source for peptide 12, it is thus conceivable that the
inefficient recognition of AK7-infected SC.Kb cells by AKR/
Gross MuLV-specific CTL is partly due to either a slower
rate of viral envelope translation by AK7-infected cells
and/or a slower rate of degradation that would result in
lower KSPWFTTL production. Implicit in this explanation
is the concept that the mature p15TM protein or envelope
precursor that is destined to become cell surface and
virion-associated gp70/p15TM is not the only, or perhaps
the primary, source for peptide 12. Whatever the identity
of the important polypeptide precursor for peptide 12,
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the measurement of mature p15TM or the env precursor
under steady-state conditions may not provide an accurate assessment of its total availability for processing
into peptide 12 for presentation by MHC class I. The
recently proposed model by Yewdell et al. (1996) that
defective ribosomal products [DRiPs], as byproducts of
protein synthesis, can be a significant source of antigenic
peptides supports our concept that the net [LTR driven]
rate of production of a precursor, other than mature virion
proteins, is what is limiting. Because of the partial effect
observed with the chimeric LTR virus, however, the data
are also suggestive that other mechanisms may exist.
Although speculative, it is possible that multiple sequence variations may act in a cooperative mechanism to
affect proteolytic and/or nonproteolytic processing steps
necessary for the display of KSPWFTTL by H-2Kb.
Although the exact mechanisms causing the poor presentation of the immunodominant KSPWFTTL epitope are
thus unresolved, it was important to determine whether
AK7 interfered globally with the presentation of other
class I-presented epitopes. As an incisive system for
comparison, we tested whether AK7 interfered with the
presentation of another H-2Kb-restricted T cell epitope
by employing recombinant vaccinia virus vectors encoding for either full-length ovalbumin [OVA] or the minimal
T cell epitope [SIINFEKL] to infect SC.Kb cells chronically
harboring AK7 or AKR623. Using the SIINFEKL specific,
CD8/ T hybridoma RF33.70, we were able to measure
SIINFEKL presentation through its production of IL-2
upon antigen stimulation. In two initial experiments the
results, obtained from an IL-2 bioassay, demonstrated
that relative to the presentation of exogenous SIINFEKL
peptide which does not require processing, AK7 does
not significantly impair the ability of SIINFEKL to be processed from OVA and presented by H-2Kb at the cell
surface [data not shown]. Although there was some variation in the stimulation of RF33.70 cells by SC.Kb, SC.Kb
cells infected by AK7, and SC.Kb cells infected by AKR623
in the two experiments, there were no differences that
were consistent or of sufficient magnitude to account for
the very poor recognition of AK7-infected cells by AKR/
Gross MuLV-specific CTL. Thus, there was no evidence
for global or trans effects by AK7 on the processing and
presentation of other class I presented epitopes.
In summary, AK7 represents an interesting mechanistic phenomenon. Although AK7 encodes for an immunodominant CTL epitope, cells infected by this MuLV are
very inefficiently recognized. AK7 thus provides an opportunity for future investigations on how retroviruses may
evade efficient CTL recognition.

231

expressing H-2Kb, OVA, and SIINFEKL. We also thank Dr. Paul Guyre
[Dartmouth Medical School] for providing the EG7 and RF33.70 cell
lines generously supplied by Dr. Kenneth L. Rock [Harvard Medical
School]. We appreciate the helpful comments and suggestions made by
Kathy Green, Robert Rich, and Shawn-Marie Mayrand. The Dartmouth
Medical School irradiation facilities, Molecular Biology Core Facility
and the flow cytometers, the generous gift of the Fannie Rippel Foundation, are partially supported by the NIH core grant of the Norris Cotton
Cancer Center, CA-23108. This work was supported by the National
Cancer Institute Grant CA-69525 to William R. Green. Victor Kim is
supported by the institutional NIH Training Grant AI-07363.

REFERENCES

The authors sincerely thank Rendall R. Strawbridge, Douglas A.
Roeder, Dr. Hillary D. White, and Dr. Michael A. Coppola for their valuable technical assistance with the viral recombinants used in this study.
We gratefully acknowledge Dr. Jack Bennink and Dr. Jonathan W. Yewdell [NIAID/NIH] for kindly providing the recombinant vaccinia viruses

Bergmann, C. C., Tong, L., Cua, R., Sensintaffar, J., and Stohlman, S.
(1994). Differential effects of flanking residues on presentation of
epitopes from chimeric peptides. J. Virol. 68, 5306–5310.
Bergmann, C. C., Yao, Q., Ho, C., and Buckwold, S. L. (1996). Flanking
residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 157, 3242–3249.
Boral, A. L., Okenquist, S. A., and Lenz, J. (1989). Identification of the
SL3-3 virus enhancer core as a T-lymphoma cell specific element.
J. Virol. 63, 76–84.
Chattopadhyay, S. K., Lander, M. R., Gupta, S., Rands, E., and Lowy,
D. R. (1981). Origin of mink cytopathic focus-forming (MCF) viruses:
Comparison with ecotropic and xenotropic murine leukemia virus
genomes. Virology 113, 465–483.
Chimini, G., Pala, P., Sire, J., Jordan, B. R., and Maryanski, J. L. (1989).
Recognition of oligonucleotide-encoded T cell epitopes introduced
into a gene unrelated to the original antigen. J. Exp. Med. 169, 297–
302.
Cloyd, M. W., Thompson, M. M., and Hartley, J. W. (1985). Host range
of mink cell focus-inducing viruses. Virology 140, 239–248.
Coppola, M. A., and Green, W. R. (1994). Cytotoxic T lymphocyte responses to the envelope proteins of endogenous ecotropic and mink
cytopathic focus-forming murine leukemia viruses in H-2b mice. Virology 202, 500–505.
Coppola, M. A., Green, W. R., and Rich, R. F. (1996). Impaired generation
of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in
mice experimentally infected with MuLV. Viral Immunol. 9, 107–119.
Coppola, M. A., Lam, T. M., Strawbridge, R. R., and Green, W. R. (1995).
Recognition of endogenous ecotropic murine leukaemia viruses by
anti-AKR/Gross virus cytotoxic T lymphocytes (CTL): Epitope variation
in a CTL-resistant virus. J. Gen. Virol. 76, 635–641.
Couillin, I., Culmann-Penciolelli, B., Gomard, E., Choppin, J., Levy, J.,
Guillet, J., and Saragosti, S. (1994). Impaired cytotoxic T lymphocyte
recognition due to genetic variations in the main immunogenic region
of the human immunodeficiency virus 1 NEF protein. J. Exp. Med.
180, 1129–1134.
Dai, H. Y., Etzerodt, M., Baekgaard, A. J., Lovmand, S., Jorgensen, P.,
Kjeldgaard, N. O., and Pedersen, F. S. (1990). Multiple sequence elements in the U3 region of the leukemogenic murine retrovirus SL32 contribute to cell-dependent gene expression. Virology 175, 581–
585.
Davidson, I., Xiao, Jia, H., Rosales, R., Staub, A., and Chambon, P. (1988).
The HeLa cell protein TEF-1 binds specifically and cooperatively to
two SV40 enhancer motifs of unrelated sequece. Cell 54, 931–942.
Del Val, M., Schlicht, H., Ruppert, T., Reddehase, M. J., and Koszinowski,
U. H. (1991). Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring
residues in the protein. Cell 66, 1145–1153.
DesGroseillers, L., and Jolicoeur, P. (1984). The tandem direct repeats
within the long terminal repeat of murine leukemia viruses are the
primary determinant of their leukemogenic potential. J. Virol. 52, 945–
952.
Eggers, M., Boes-Fabian, B., Ruppert, T., Kloetzel, P., and Koszinowski,
U. H. (1995). The clevage preference of the proteasome governs the
yeild of antigenic peptides. J. Exp. Med. 182, 1865–1870.

AID

viral

ACKNOWLEDGMENTS

VY 8747

/

6a46$$$341

09-02-97 05:32:33

AP: VY

232

KIM AND GREEN

Eisenlohr, L. C., Yewdell, J. W., and Bennink, J. R. (1992). Flanking sequences influence the presentation of an endogenously synthesized
peptide to cytotoxic T lymphocytes. J. Exp. Med. 175, 481–487.
Elder, J. H., Gautsch, J. W, Jensen, F. C., Lerner, R. A., Hartley, J. W., and
Rowe, W. P. (1977). Biochemical evidence that MCF murine leukemia
viruses are envelope (env) gene recombinants. Proc. Natl. Acad. Sci.
USA 74, 4676–4680.
Fu, T., Bonneau, R. H., Tevethia, M. J., and Tevethia, S. S. (1993). Simian
virus 40 T antigen as a carrier for the expression of cytotoxic Tlymphocyte recognition epitopes. J. Virol. 67, 6866–6871.
Gillis, S., Ferm, M. M., Ou, W., and Smith, K. A. (1978). T cell growth
factor: Parameters of production and a quantitative microassay for
activity. J. Immunol. 120, 2027–2032
Graves, B. J., Eisenman, R. N., and McKnight, S. L. (1985). Delineation
of transcriptional control signals within the moloney murine sarcoma
virus long terminal repeat. Mol. Cell. Biol. 5, 1948–1958.
Green, W. R. (1980). H-2 restricted cytolytic T lymphocytes specific for a
subclass of AKR endogenous murine leukemia virus-induced tumors:
Correlation of tumor cell susceptibility with expression of the gross
cell surface antigen. J. Immunol. 125, 2584–2590.
Green, W. R. (1982). The in vitro generation of H-2-restricted cytotoxic
T cells to AKR/Gross leukemia virus-induced tumors. J. Immunol.
128, 1043–1049.
Green, W. R. (1984). Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. J. Immunol. 132,
2658–2664.
Green, W. R., and Graziano, R. F. (1986). Cytolytic T lymphocyte-defined
retroviral antigens on normal cells: Encoding by the Akv-1 proviral
locus. Immunogenetics 23, 106–110.
Green, W. R., and Smith, P. M. (1996). Endogenous ecotropic and recombinant MCF mouse retroviral variation and escape from antiviral
CTL. Semin. Virol. 7, 49–60.
Green, W. R., Nowinski, R. C., and Henney, C. S. (1979). The generation
and specificity of cytotoxic T cells raised against syngeneic tumor
cells bearing AKR/Gross murine leukemia virus antigens. J. Exp. Med.
150, 51–66.
Hahn, Y. S., Braciale, V. L., and Braciale, T. J. (1991). Presentation of
viral antigen to class I major histocompatibility complex-restricted
cytotoxic T lymphocyte. Recognition of an immunodominant influenza
hemagglutinin site by cytotoxic T lymphocyte is independent of the
position of the site in the hemagglutinin translation product. J. Exp.
Med. 174, 733–736.
Hahn, Y. S., Hahn, C. S., Braciale, V. L., Braciale, T. J., and Rice, C. M.
(1992). CD8/ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp.
Med. 176, 1335–1341.
Hallberg, B., and Grundstrom, T. (1988). Tissue specific sequence motifs in the enhancer of the leukaemongenic mouse retrovirus SL3-3.
Nucleic Acids Res. 16, 5927–5944.
Hartley, J. W., Wolford, N. K., Old, L. J., and Rowe, W. P. (1977). A new
class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Natl. Acad. Sci. USA 74, 789–792.
Herr, W. (1984). Nucleotide sequence of AKV murine leukemia virus. J.
Virol. 49, 471–478.
Kelly, M., Holland, C. A., Lung, M., Chattopadhyay, Lowy, D. R., and
Hopkins, N. H. (1983). Nucleotide sequence of the 3* end of MCF
247 murine leukemia virus. J. Virol. 45, 291–298.
Khan, A. S. (1984). Nucleotide sequence analysis establishes the role
of endogenous murine leukemia virus DNA segments in formation
of recombinant mink cell focus-forming murine leukemia viruses. J.
Virol. 50, 864–871.
Koup, R. A. (1994). Virus escape from CTL recognition. J. Exp. Med.
180, 779–782.
Lenz, J., personal communication.
LoSardo, J. E., Cupelli, L. A., Short, M. K., Berman, J. W., and Lenz, J.
(1989). Differences in activities of murine retroviral long terminal
repeats in cytotoxic T lymphocytes and T-lymphoma cells. J. Virol.
63, 1087–1094.

Lostrom, M. E., Stone, M. R., Tam, M., Burnette, W. N., Pinter, A., and
Nowinski, R. C. (1979). Monoclonal antibodies against murine leukemia viruses: Identification of six antigenic determinants on the p15(E)
and gp70 envelope proteins. Virology 98, 336–350.
Lovmand, S., Kjeldgaard, N. O., Jorgensen, P., and Pedersen, F. S.
(1990). Enhancer functions in U3 of Akv virus: A role for cooperativity
for a tandem direct repeat unit and its flanking DNA sequences. J.
Virol. 64, 3185–3191.
Moore, M. W., Carbone, F. R., and Bevan, M. J. (1988). Introduction of
soluble protein into the class I pathway of antigen processing and
presentation. Cell 54, 777–785.
Morrison, H. L., Soni, B., and Lenz, J. (1995). Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell
lymphomas induced by a murine retrovirus. J. Virol. 69, 446–455.
Mylin, L. M., Bonneau, R. H., Lippolis, J. D., and Tevethia, S. S. (1995).
Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69, 6665–6677.
Neisig, A., Roelse, J., Sijts, A., Ossendorp, F., Feltkamp, M., Kast, M.,
Melief, C., and Neefjes, J. J. (1995). Major differences in transporter
associated with antigen presentation [TAP]-dependent translocation
of MHC class I presentable peptides and the effect of flanking sequences. J. Immunol. 154, 1273–1279.
Niedermann, G., Butz, S., Ihlenfeldt, H., Grimm, R., Lucchiari, M.,
Hoschutzky, H., Jung, G., Maier, B., and Eichmann, K. (1995). Contribution of proteasome-mediated hydolysis to the hierarchy of epitopes
presented by major histocompatibility complex class I moleules. Immunity 2, 289–299.
Ossendorp, F., Eggers, M., Neisig, A., Ruppert, T., Groettrup, M., Sijts,
A., Mengede, E., Kloetzel, P., Neefjes, J., Koszinowski, U., and Melief,
C. (1996). A single residue exchange within a viral CTL epitope alters
proteasome-mediated degredation resulting in a lack of antigen presentation. Immunity 5, 115–124.
Ozato, K., and Sachs, D. H. (1981). Monoclonal antibodies to mouse
MHC antigens. J. Immunol. 126, 317–321.
Pinter, A., Honnen, W. J., Tung, J. S., O’Donnell, P. V., and Hammerling,
U. (1982). Structural domains of endogenous murine leukemia virus
gp70s containing specific antigenic determinants defined by monoclonal antibodies. Virology 116, 499–516.
Portis, J. L., McAtee, F. J., and Cloyd, M. W. (1982). Monoclonal antibodies to xenotropic and MCF murine leukemia viruses derived during
the graft-versus-host reaction. Virology 118, 181–190.
Rammensee, H. G., Falk, K., and Rotzschke, O. (1993). Annu. Rev. Immunol. 11, 213–244.
Rammensee, H. G., Friede, T., and Stevanovic, S. (1995). MHC ligands
and peptide motifs: first listing. Immunogenetics 41, 178–228.
Rich, R. F., and Green, W. R. (1988). Genetic control of CTL responses
to AKR/Gross virus: effect of inheritance of Akv proviruses. Immunogenetics 27, 304–312.
Rock, K. L., Rothstein, L., and Gamble, S. (1990). Generation of class I
MHC-restricted T-T hybridomas. J. Immunol. 145, 804–811.
Shastri, N., Serwold, T., and Gonzalez, F. (1995). Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by
specific C-terminal flanking residues. J. Immunol. 155, 4339–4346.
Sijts, A., Ossendorp, F., Mengede, E., Elsen, P., and Melief, C. (1994).
Immunodominant mink cell focus-inducing murine leukemia virus
(MuLV)-encoded CTL epitope, identified by its MHC class I-binding
motif, explains MuLV-type specificity of MCF-directed cytotoxic T
lymphocytes. J. Immunol. 152, 106–116.
Speck, N. A., and Baltimore, D. (1987). Six distinct nuclear factors interact with the 75 base pair repeat of the moloney murine leukemia
virus enhancer. Mol. Cell. Biol. 7, 1101–1110.
Speck, N. A., Renjifo, B., Golemis, E., Fredrickson, T. N., Hartley, J. W.,
and Hopkins, N. (1990). Mutation of the core or adjacent LVb elements of the moloney murine leukemia virus enhancer alters disease
specificity. Genes Dev. 4, 233–242.
Steffen, D. L., Taylor, B. A., and Weinberg, R. A. (1982). Continuing germ
line integration of AKV proviruses during the breeding of AKR mice
and derivative recombinant inbred strains. J. Virol. 42, 165–175.

AID

viral

VY 8747

/

6a46$$$341

09-02-97 05:32:33

AP: VY

CTL RESPONSES TO THE AK7 MuLV

233

Stoye, J. P., Moroni, C., and Coffin, J. M. (1991). Virological events leading to spontaneous AKR thymomas. J. Virol. 65, 1273–1285.
Thomas, C. Y., Nuckols, J. D., Murphy, C., and Innes, D. (1993). Generation and pathogenicity of an NB-tropic SL3-3 murine leukemia virus.
Virology 193, 1013–1017.
White, H. D., Green, W. R., and Gine, N. R. (1993). Molecular cloning of
infectious ecotropic murine leukemia virus AK7 from an emv-14positive AKXL-5 mouse and the resistance of AK7 to recognition by
cytolytic T lymphocytes. J. Virol. 67, 5045–5050.
White, H. D., Robbins, M. D., and Green, W. R. (1990). Mechanism of
escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR/Gross virus cytolytic T lymphocytes. J. Virol. 64,
2608–2619.
White, H. D., Roeder, D. A., and Green, W. R. (1994a). An immunodominant Kb-restricted peptide from the p15E transmembrane protein of
endogenous ecotropic murine leukemia virus (MuLV) AKR623 that

restores susceptibility of a tumor line to anti-AKR/Gross MuLV cytotoxic T lymphocytes. J. Virol. 68, 897–904.
White, H. D., Roeder, D. A., Lam, T., and Green, W. R. (1994b). Major
and minor Kb-restricted epitope by the endogenous ecotropic murine
leukemia virus AKR623 that are recognized by anti-AKR/Gross MuLV
CTL. Viral Immunol. 7, 51–59.
Yellen-Shaw, A. J., and Eisenlohr, L. C. (1997a). Regulation of class I
restricted epitope processing by local or distal flanking sequence.
J. Immunol. 158, 1727–1733.
Yellen-Shaw, A. J., Wherry, E. J., Dubois, G. C., and Eisenlohr, L. C.
(1997b). Point mutation flanking a CTL epitope ablates in vitro and
in vivo recognition of a full length viral protein. J. Immunol. 158, 3227–
3234.
Yewdell, J. W., Anton, L. C., and Bennink, J. R. (1996). Defective ribosomal products (DRiPs): A major source of antigenic peptides for
MHC class I molecules? J. Immunol. 157, 1823–1826.

AID

viral

VY 8747

/

6a46$$$341

09-02-97 05:32:33

AP: VY

